SugenTech

SugenTech Current Ratio

The Current Ratio of SugenTech (253840.KQ) as of Oct 19, 2026 is 12.46. In the previous year, Current Ratio was 10.23 — a change of 21.73% (higher).

Current Ratio

12.46

YoY

21.73%

Last updated:

Current Ratio of SugenTech is 2025 12.46 . Current Ratio of SugenTech was 2024 10.23 . It decreases by 21.73% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SugenTech Stock analysis

What does SugenTech do? SugenTech Inc., headquartered in Daejeon, South Korea, operates in the Health Care sector, specializing in in-vitro diagnostic systems and products. The company develops and sells diagnostic test reagents, point-of-care testing (POCT) products under INCLIX, and personal-use test kits under SUREARLY. It also manufactures folic acid products under SOLGAR and molecular diagnostic reagents. SugenTech distributes its offerings domestically and internationally, including in Indonesia, focusing on therapeutic drug monitoring and drug analysis method development. SugenTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SugenTech stock

Current Ratio of SugenTech is 12.46 in 2025.

Current Ratio of SugenTech changed from 10.23 to 12.46, representing a 21.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio SugenTech since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's SugenTech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — SugenTech

All Key Metrics — SugenTech